Zhang, Z., Shi, M., Li, Z., Ling, Y., Zhai, L., Yuan, Y., . . . Hölscher, C. A Dual GLP-1/GIP Receptor Agonist Is More Effective than Liraglutide in the A53T Mouse Model of Parkinson’s Disease. Wiley.
Chicago Style (17th ed.) CitationZhang, Zijuan, et al. A Dual GLP-1/GIP Receptor Agonist Is More Effective than Liraglutide in the A53T Mouse Model of Parkinson’s Disease. Wiley.
MLA (9th ed.) CitationZhang, Zijuan, et al. A Dual GLP-1/GIP Receptor Agonist Is More Effective than Liraglutide in the A53T Mouse Model of Parkinson’s Disease. Wiley.
Warning: These citations may not always be 100% accurate.